| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Sep 17, 2009 |
|||||||||
| - | $0.58 | $0.58 | $8.01B | $8.01B |
NYSE |
||||
| Q3 FY09 | $1.07 | -$0.11 | $1.62B | $390.25M |
NYSE |
||||
|
The Marcus
MCS
|
Q1 FY10 | $0.34 | $0.38 | $110.15M | $123.16M |
NYSE |
|||
|
Pro-Dex
PDEX
|
- | $0.06 | - | $5.62M | - |
NASDAQ |
|||
|
PharmaCyte Biotech
PMCB
|
- | -$4.33 | - | $67.95K | - |
NASDAQ |
|||
